Work

Discovery of JANUVIA™ (Sitagliptin), a Selective Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type2 Diabetes.

Year: 2007

Type: article

Source: Current Topics in Medicinal Chemistry

DOI: 10.2174/156802607780091028

Authors: Nancy Thornberry, Ann Weber

Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1991635121

FWCI: 10.24

Cites:

Cited by: 205

Related to: 10